Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
Animals
Antitubercular Agents
/ chemical synthesis
Cell Line, Tumor
Cell Proliferation
/ drug effects
Chlorocebus aethiops
Dose-Response Relationship, Drug
Drug Design
Humans
Microbial Sensitivity Tests
Molecular Docking Simulation
Molecular Dynamics Simulation
Molecular Structure
Mycobacterium tuberculosis
/ drug effects
Pyrazoles
/ chemical synthesis
Pyrimidines
/ chemical synthesis
Structure-Activity Relationship
Vero Cells
Molecular docking
Molecular dynamics
Mycobacterium tuberculosis
Pyrazolo[1,5-a]pyrimidine hybrids
Journal
Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
01
12
2018
revised:
23
01
2019
accepted:
20
02
2019
pubmed:
26
3
2019
medline:
23
9
2020
entrez:
26
3
2019
Statut:
ppublish
Résumé
In-depth study of structure-based drug designing can provide vital leads for the development of novel, clinically active molecules. In this present study, twenty six novel pyrazolo[1,5-a]pyrimidine analogues (6a-6z) were designed using molecular docking studies. The designed molecules were synthesized in good yields. Structural elucidation of the synthesized molecules was carried out using IR, MS,
Identifiants
pubmed: 30908967
pii: S0045-2068(18)31401-9
doi: 10.1016/j.bioorg.2019.02.044
pii:
doi:
Substances chimiques
Antitubercular Agents
0
Pyrazoles
0
Pyrimidines
0
pyrazolo(1,5-a)pyrimidine
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
240-251Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.